59th Medical Wing/ST


FLC Region

Security Lab



1100 Wilford Hall Loop, Building 4554
Joint Base San Antonio-Lackland, TX 78236-9854
United States

Want more information? Contact a representative below.


(801) 309-0517


The mission of the 59th Medical Wing Chief Scientist's Office, Science and Technology (59MDW/ST) is to provide strategic leadership, scientific, technical, bio-statistical, research and regulatory compliance, and program management guidance and support for clinical investigations, studies and translational research conducted by investigators and their collaborators to address unique scientific needs of the 59th Medical Wing, Defense Health Agency (DHA), United States Air Force and Air Force Medical Service (AFMS), joint medical R&D community, Department of Defense (DoD), and the Nation.  This specialized expertise enables researchers to exploit new knowledge while developing, evaluating, and integrating applications of innovative technologies to provide the very best patient-centered care in the pre-hospital, in- and -out-patient environment, maintaining and restoring warfighter and beneficiary health, and building warrior medics to address present and future mission challenges.  The ST office supports clinical researchers at over 70 sites worldwide. Authority for 59 MDW clinical research is granted generally by 10 USC §2358. More specifically, authority is provided through DOD Directive 6200.04, Force Health Protection, which states "The Department of Defense shall pursue scientific and technological advancements to improve and protect the health of the force through medical research, development, clinical investigations, technology insertion, and appropriate acquisition strategies."

Mission: Conduct clinical studies and translational research and apply knowledge gained to enhance performance, protect the force, and advance medical care and capabilities across the global health system, and train future medical leaders.

Vision: Grow Medical Leaders, Drive Innovations in Patient Care and Readiness

Group Email: usaf.jbsa.59-mdw.mbx.59-mdw-st-technology-transfer-office@mail.mil




The AFMS laboratory executes a multifaceted program of phased efforts to develop knowledge and/or enhance technical sophistication of novel devices, systems, drugs, biologics and other medical products related to diagnosis, treatment, and maintenance of clinical health problems of concern to beneficiaries of military healthcare and used in aerospace expeditionary operations to preserve service members' health and mission capabilities. AFMS research is highly distributed encompassing AFMS researchers assigned to and conducting research at AFMS and other DOD, federal, and nonfederal healthcare, academic and research activities. The Director of Research and Acquisitions, Air Force Medical Support Agency, Office of the Surgeon General (AFMSA/SG5), oversees research, development, acquisition, and transitioning of required capabilities into fielded medical systems. This includes research, development and acquisition requirements determination, modernization strategies, and advocating for resources to support research, development, acquisition, testing and evaluation, and operational and oversight authority of the Air Force Medical Service Office of Research and Technology Applications (AFMS ORTA) on behalf of the Air Force Surgeon General. AFMS ORTA located at AFMSA/SG5M-South (San Antonio, Texas) serves as the focal point for clinical research technology transfer. We support translation of clinical research into practice, facilitating clinical researchers' collaborations with industry and academia, and enabling the Air Force Surgeon General to realize benefits from research investments. Our scope does not address aerospace medical or other nonmedical research technology transfer as other Air Force ORTAs provide this support. The AFMS ORTA provides the collaborative environment necessary to effectively transfer research to nonfederal entities for commercialization and introduction into medical practice. Medical technology emerging from the AFMS, in most cases, has a broader application to civilian medical practice than to military medical practice. This does not diminish the military impact of this medical technology. However, it does imply all such technologies should be carefully examined as to their domestic technology transfer potential to enhance the public benefit of defense health program expenditures on clinical research.


No Technologies


No Facilities


No Equipment


No Programs


No Funds


No Publications


No News


No Successes


No Licenses